Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter.
about
Transcriptional Targeting in Cancer Gene TherapyPotential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stressCharacterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization.Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- miceTargeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditisDifferential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle.High-salt in addition to high-fat diet may enhance inflammation and fibrosis in liver steatosis induced by oxidative stress and dyslipidemia in mice.The role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights.Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice.VB-111: a novel anti-vascular therapeutic for glioblastoma multiformeVascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment.Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotypeEffect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts.Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.Transcriptional targeting of tumor endothelial cells for gene therapy.VB-111 for cancer.Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials.Phase II angiogenesis stimulators.In vitro targeted gene electrotransfer to endothelial cells with plasmid DNA containing human endothelin-1 promoter.Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequencesOverexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy.Localized methylation in the key regulator gene endothelin-1 is associated with cell type-specific transcriptional silencing.Transcription-controlled gene therapy against tumor angiogenesis.Inhibitors of endothelin.Octamer-dependent in vivo expression of the endothelial cell-specific TIE2 gene.Functional analysis of the endothelial cell-specific Tie2/Tek promoter identifies unique protein-binding elements.Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models.Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo.Tissue-specific gene therapy directed to tumor angiogenesis.Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.Transgenic animal models for the functional analysis of vasoactive peptides.Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences.
P2860
Q24791038-A562A6CE-A970-42C2-8896-383A4E528E43Q28344704-8DBFDC40-BEA9-43B2-B269-C25B98DAB6E2Q28504628-C38B64E5-5C6A-497E-9B2F-5F13D156554FQ30444108-E7CBAB13-04EB-48D2-A172-C28CD1AA5370Q33849246-B41F9CF8-B90A-48C6-BC27-64D8A0A484E1Q34399952-03FA0756-686B-483B-8A59-460AB9683419Q34568916-8FF4579B-F773-4CA4-9E38-6CB45BFD254FQ35109935-9AB349E0-479D-43EE-9B55-8E940C51A105Q36067020-071868AF-9CCF-4AD2-A2AF-F49705A65A91Q36077023-F21DF633-4B26-4EB7-8031-4B714F29DE63Q36096024-60A59BDB-A151-4572-A95C-AFA42ADA8A63Q36263590-B86485F4-F4EB-4D40-A6F0-2C6E417ABA3CQ37000190-79C66795-B4A6-47C0-926D-099DC50AF80CQ37351138-24D98B36-A2F5-495A-B669-58B3133D65D6Q37388154-2444AC95-FB12-42F2-BCF4-9E472F5330F8Q37459648-02360EB2-1916-427B-8323-D3A4851BF45EQ37941051-5B86EF34-5BC9-4674-B536-BC23CFE9637EQ37961586-DBF4BF25-1646-4E46-B0A6-91D406FE020CQ38116090-21F1EA6D-1766-442D-83EE-29F14283BED3Q39154948-6F8F65AF-C8D1-4635-B9E1-B7E712EA0E73Q39596785-AEF761C4-656A-46C2-BB8E-94BD1A90B372Q40244986-345159C5-1D11-4D16-81B8-894367DC557CQ40251244-34F5262C-4AE3-4262-9A5F-C3548E4CCE4AQ40725919-55C79864-84E2-4769-BB77-26FC5E757725Q41287170-72DF589C-1C78-4EEE-9421-0718ACEBE710Q41678268-D37C1B62-3A0F-4D3A-83FD-D974CB6194D5Q41887700-82AA34D6-7B1C-48F4-BBAA-D7DF40113E64Q42200679-87A0E794-1890-45A1-B29E-215D5026DD33Q45865684-53FFC3E7-50ED-4BD4-B2FB-570F0F4B6A18Q45878125-9B9CF98F-9872-4174-AD81-F7878184F43DQ47725988-30D5BDA0-66B2-4CBA-A89D-D0F822A104FBQ52981348-9A0B8918-0A00-4C41-93C2-7B98D79587B3Q53421892-9CDCA849-BFC0-4018-9D70-7C4E21A29B30
P2860
Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Targeting gene expression to t ...... e preproendothelin-1 promoter.
@ast
Targeting gene expression to t ...... e preproendothelin-1 promoter.
@en
type
label
Targeting gene expression to t ...... e preproendothelin-1 promoter.
@ast
Targeting gene expression to t ...... e preproendothelin-1 promoter.
@en
prefLabel
Targeting gene expression to t ...... e preproendothelin-1 promoter.
@ast
Targeting gene expression to t ...... e preproendothelin-1 promoter.
@en
P2093
P2860
P356
P1476
Targeting gene expression to t ...... e preproendothelin-1 promoter.
@en
P2093
H Kurihara
Y Kurihara
P2860
P304
P356
10.1172/JCI117784
P407
P577
1995-03-01T00:00:00Z